Medhat El-Sebaie

Genetics and genomics of radiotherapy toxicity: towards prediction

Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma

Radiomics: Images Are More than Pictures, They Are Data

Nasopharyngeal carcinoma

Nonurothelial Bladder Cancer and Rare Variant Histologies

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

Global cancer statistics

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

Nasopharyngeal carcinoma

Bladder cancer

Induction Chemotherapy with Nedaplatin with 5-FU Followed by Intensity-modulated Radiotherapy Concurrent with Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

The impact of variant histology on the outcome of bladder cancer treated with curative intent

The changing patterns of bladder cancer in Egypt over the past 26 years

The status of platinum anticancer drugs in the clinic and in clinical trials

Radiogenomics helps to achieve personalized therapy by evaluating patient responses to radiation treatment

Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer

The Sensitivity of Initial Transurethral Resection or Biopsy of Bladder Tumor(s) for Detecting Bladder Cancer Variants on Radical Cystectomy

Among 45 variants in 11 genes, HDM2 promoter polymorphisms emerge as new candidate biomarker associated with radiation toxicity

Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and management

Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma

Association between Normal Tissue Complications after Radiotherapy and Polymorphic Variations inTGFB1andXRCC1Genes